Upstream Bio Insider Sales, Phase 2 Results, and Upside Potential
Upstream Bio’s insider sell‑to‑cover trades are tax‑moves, not a loss of confidence. With Phase 2 Privosegtor data due soon, investors can watch post‑presentation price action for a possible rally, while staying alert to future insider activity and …
4 minutes to read
